Chris Howerton

Stock Analyst at Jefferies

(0)
# 4575
Out of 5,386 analysts
100
Total ratings
Success rate
Average return
45 Stocks
Name Action PT Current % Upside Ratings Updated
ARDX Ardelyx
Maintains: Buy
11 8
3.71 115.63% 5 Jan 2, 2025
GPCR Structure Therapeuti...
Maintains: Strong Buy
50 79
21.11 274.23% 2 Sep 29, 2023
PNT POINT Biopharma Glob...
Assumes: Strong Buy
12 14
n/a n/a 3 Jul 20, 2023
MIST Milestone Pharmaceut...
Downgrades: Hold
8 4
1.86 115.05% 4 Jun 20, 2023
VERU Veru
Upgrades: Hold
1
0.6 66.67% 3 Jun 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25
n/a n/a 4 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
320 352
1.76 19900% 2 Mar 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1 1
n/a n/a 3 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
720
4.71 15186.62% 2 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
1
1.66 -69.88% 2 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
35 10
13.48 -25.82% 1 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
8 2
2.81 -28.83% 3 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
2 1
n/a n/a 3 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
18
n/a n/a 1 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7 11
9.21 19.44% 3 Nov 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
30 20
n/a n/a 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
70 40
17.43 129.49% 2 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
57 61
31.98 90.74% 3 Oct 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
92 90
103.39 -12.95% 3 Sep 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
870 510
n/a n/a 2 Apr 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
180 183
n/a n/a 2 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
23 2
n/a n/a 2 Mar 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
24 12
4.79 150.52% 5 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
100
n/a n/a 3 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
101 126
1.13 11050.44% 1 Dec 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
20
1.41 1318.44% 1 Nov 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
66
20.29 225.28% 4 Sep 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
n/a n/a 1 Aug 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
4.9 348.98% 1 Aug 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
1.43 1368.53% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
22
1.03 2035.92% 1 May 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
4
n/a n/a 1 Apr 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
23
1.31 1655.73% 1 Apr 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
220 360
n/a n/a 3 Apr 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
40 21
22.09 -4.93% 4 Apr 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
7 5
n/a n/a 2 Mar 12, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
6
n/a n/a 3 Dec 10, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
55 88
n/a n/a 2 Sep 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
8
n/a n/a 1 Aug 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
19
n/a n/a 1 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
80 580
9.12 6259.65% 2 Aug 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
63 60
1.11 5305.41% 1 Aug 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
16
73.27 -78.16% 2 Aug 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
27
55.71 -51.53% 1 Jul 15, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
1200
9.26 12858.96% 1 May 26, 2020